Avastin/Tarceva vs. Iressa/4601
All makes sense now:
https://www.medicalnewstoday.com/articles/137689.php
Roche owns both Avastin (from Genentech) and Tarceva (from licensing deal with OSI).
Combo trial was a heralded success for lung cancer.
Unless AstraZeneca can show some sort of awesome results, Iressa will still be second best. Note currently best of class for Asian mutations (Chinese, Japanese and the others alike). Second for white and black people.
However... with 4601. Best of class in all is possible in term of effectiveness and check this out ! Best of class in term of side effect.
Combo 4601/Iressa much less side effect than Avastin/Tarceva.
Will Roche mount a bidding war for TLN?
Well well well it was
AstraZeneca all along!